Forskning ved Københavns Universitet - Københavns Universitet

Forside

Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Watt, Torquil
  • Alessandro P Burlina
  • Chiara Cazzorla
  • Dorothee Schönfeld
  • Maryam Banikazemi
  • Robert J Hopkin
  • Ana Maria Martins
  • Katherine Sims
  • Dana Beitner-Johnson
  • Fanny O'Brien
  • Feldt-Rasmussen, Ulla
To evaluate the effect of agalsidase beta on longitudinal health-related quality of life in patients with Fabry disease.
OriginalsprogEngelsk
TidsskriftJournal of Endodontics
Vol/bind12
Udgave nummer11
Sider (fra-til)703-12
Antal sider10
ISSN0099-2399
DOI
StatusUdgivet - 1 nov. 2010

ID: 34197994